SBFM Q2 2017 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q2 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$472,218

Net Income

-$485,444

EPS (Diluted)

$-97088.80

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$77,813

Free Cash Flow

-$100,108

Stock-Based Comp.

$336,000

Balance Sheet

Total Assets

$164,335

Total Liabilities

$780,624

Stockholders' Equity

-$616,289

Cash & Equivalents

$128,768

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$7,761	+100.0%
Operating Income	-$472,218	-$471,313	-0.2%
Net Income	-$485,444	-$481,310	-0.9%